Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00754208 · ClinicalTrials.gov registry record · Phase 4
Long Acting Stimulant Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Young Children
A Phase 4 study, sponsored by University of Nebraska.
- Completed
- Registry status
- Phase 4
- Development phase
- 7
- Enrollment target
NCT00754208 is a Phase 4 study that has completed, run by University of Nebraska. The registered enrollment target is 7 participants.
The verdict
NCT00754208, a Phase 4 study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 7 participants
- Enrollment target
Study Summary
This is a pilot study evaluating the effectiveness, safety, and tolerability of Ritalin LA in treating Attention Deficit Hyperactivity Disorder (ADHD) in 4 and 5 year old children. Virtually no data has been published on the use of long-acting stimulant preparations in very young children despite early symptomatic development in a significant portion of young children with ADHD. This would be one of the first studies looking at a long-acting preparation of a stimulant medication in the treatment of ADHD in very young children. Hypotheses 1. Ritalin LA is effective for the treatment of ADHD in 4 and 5 year old children. 2. Ritalin LA is reasonably well-tolerated in the treatment of ADHD in 4 and 5 year old children.
Interventions
- DRUG methylphenidate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2008-09-18 |
| Est. Completion | 2010-01-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00754208
The ClinicalTrials.gov registry entry for NCT00754208 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which methylphenidate is the first listed.
NCT00754208 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00754208 about?
NCT00754208 is a clinical study titled "Long Acting Stimulant Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Young Children". This is a pilot study evaluating the effectiveness, safety, and tolerability of Ritalin LA in treating Attention Deficit Hyperactivity Disorder (ADHD) in 4 and 5 year old children. Virtually no data has been published on the use of long-acting stimulant preparations in very young children despite ea...
What is the current status of trial NCT00754208?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 7 participants. The study started on 2008-09-18. Estimated completion is 2010-01-01.
What interventions are being tested in trial NCT00754208?
The interventions under investigation include: methylphenidate (DRUG).
Who is sponsoring clinical trial NCT00754208?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.